Amgen Perfectly Positioned To Deal With Prolia Complete Response Letter; Quick Turn-Around Expected
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA handed Amgen a complete response letter for Prolia, but the company has an armamentarium for handling the agency's requests.